Clinical Trials

Trial of Modifications to Radical Prostatectomy

Number: NCT01407263
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Memorial Sloan Kettering Cancer Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial

Number: NCT01411345
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2| Phase 3
Sponsor(s): University of Miami
Sponsor Trial Information
Trial Location(s) and Contact(s): University of Miami
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

Number: NCT01913106
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): The Methodist Hospital System
Sponsor Trial Information
Trial Location(s) and Contact(s)
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Number: NCT02624518
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2| Phase 3
Sponsor(s): Andrei Iagaru|National Cancer Institute (NCI)|Stanford University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Nanoparticles and Radiation or Radiation With Brachytherapy for Prostate Cancer

Number: NCT02805894
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1| Phase 2
Sponsor(s): Nanobiotix
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Olaparib in Men With High-Risk Recurrent Prostate Cancer Following Prostate Surgery

Number: NCT03047135
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor Trial Information
Trial Location(s) and Contact(s)
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Number: NCT03070886
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2| Phase 3
Sponsor(s): NRG Oncology|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Number: NCT03152786
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Wake Forest University Health Sciences|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Number: NCT03170960
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Exelixis
Sponsor Trial Information
Trial Location(s) and Contact(s)
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

Number: NCT03312972
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Loyola University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Number: NCT03315871
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Number: NCT03456843
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Rutgers, The State University of New Jersey|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Number: NCT03541850
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
BEACON: Brachytherapy, Radiation and Androgen Deprivation Therapy for the Treatment of Recurrence of Prostate Cancer After Radiation Therapy

Number: NCT03553602
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Loyola University
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

Number: NCT03572387
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Icahn School of Medicine at Mount Sinai
Sponsor Trial Information
Trial Location(s) and Contact(s)
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Number: NCT03600350
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Wisconsin, Madison|Bristol-Myers Squibb|Madison Vaccines Inc. (MVI)|AIQ Solutions
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Number: NCT03602079
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Klus Pharma Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Number: NCT03796767
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Utah
Sponsor Trial Information
Trial Location(s) and Contact(s)
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Number: NCT03830164
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Number: NCT03902951
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Jonsson Comprehensive Cancer Center|Janssen Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Number: NCT04114825
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): RhoVac APS
Sponsor Trial Information
Trial Location(s) and Contact(s)
Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Number: NCT04175431
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Washington|National Cancer Institute (NCI)|Blue Earth Diagnostics
Sponsor Trial Information
Trial Location(s) and Contact(s)
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment

Number: NCT04190446
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Mayo Clinic|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Number: NCT04336943
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Washington|National Cancer Institute (NCI)|AstraZeneca
Sponsor Trial Information
Trial Location(s) and Contact(s)
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

Number: NCT04422132
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Weill Medical College of Cornell University|Viewray Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)

Total: 25 Clinical Trials



PHEN,Inc. © 2021 All rights reserved